Cardax Pharma, Inc.

New Filing
CIK: 0001579166·Pharmaceuticals·DELAWARE·Filed: Jan 17, 2014
Total Offering

$5,000,000

Amount Sold

$2,076,000

Investors

26

First Sale

Jan 3, 2014

Offering Details

Type
Debt, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2013
Non-Accredited Investors
No

Related Persons

NameRole
David G. Watumull
Related Person
Nicholas Mitsakos
Related Person
Frank C. Herringer
Related Person

Company

Cardax Pharma, Inc.

2800 WOODLAWN DRIVE

HONOLULU, HI, 96822

808-457-1399

SEC Filing

0001579166-14-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cardax Pharma, Inc. Form D Filing — $5,000,000 | FilingFlow